Recursion Pharmaceuticals, Inc. (RXRX)
3.20
+0.04
(+1.27%)
USD |
NASDAQ |
Sep 11, 16:00
3.13
-0.07
(-2.19%)
Pre-Market: 08:10
Recursion Pharmaceuticals Price to Book Value : 1.868 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.868 |
| September 10, 2026 | 1.845 |
| September 09, 2026 | 1.877 |
| September 08, 2026 | 2.008 |
| September 04, 2026 | 2.119 |
| September 03, 2026 | 2.008 |
| September 02, 2026 | 1.973 |
| September 01, 2026 | 1.944 |
| August 31, 2026 | 1.985 |
| August 28, 2026 | 1.950 |
| August 27, 2026 | 2.008 |
| August 26, 2026 | 2.037 |
| August 25, 2026 | 2.078 |
| August 24, 2026 | 1.897 |
| August 21, 2026 | 2.043 |
| August 20, 2026 | 1.950 |
| August 19, 2026 | 2.043 |
| August 18, 2026 | 1.804 |
| August 17, 2026 | 1.815 |
| August 14, 2026 | 1.845 |
| August 13, 2026 | 1.932 |
| August 12, 2026 | 1.920 |
| August 11, 2026 | 1.956 |
| August 10, 2026 | 1.920 |
| August 07, 2026 | 1.880 |
| Date | Value |
|---|---|
| August 06, 2026 | 1.856 |
| August 05, 2026 | 1.850 |
| August 04, 2026 | 1.932 |
| August 03, 2026 | 1.856 |
| July 31, 2026 | 1.751 |
| July 30, 2026 | 1.775 |
| July 29, 2026 | 1.734 |
| July 28, 2026 | 1.780 |
| July 27, 2026 | 1.757 |
| July 24, 2026 | 1.728 |
| July 23, 2026 | 1.757 |
| July 22, 2026 | 1.740 |
| July 21, 2026 | 1.798 |
| July 20, 2026 | 1.687 |
| July 17, 2026 | 1.719 |
| July 16, 2026 | 1.763 |
| July 15, 2026 | 1.932 |
| July 14, 2026 | 1.950 |
| July 13, 2026 | 1.926 |
| July 10, 2026 | 2.078 |
| July 09, 2026 | 2.195 |
| July 08, 2026 | 2.172 |
| July 07, 2026 | 2.242 |
| July 06, 2026 | 2.312 |
| July 02, 2026 | 2.218 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 17.89 |
| Absci Corp. | 5.722 |
| Novavax, Inc. | -- |
| Editas Medicine, Inc. | 3.937 |
| Amgen, Inc. | 17.45 |
Price to Book Value Related Metrics
| PS Ratio | 29.69 |
| Price | 3.20 |
| Earnings Yield | -32.38% |
| Market Cap | 1.709B |